Cargando…
Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target
The prevalence rate of allergic diseases, such as asthma, atopic rhinitis (AR), and atopic dermatitis (AD), has been significantly increasing over the years because of environmental changes. Type 2 immunity is mediated by allergic inflammation initiated by an innate immune response. This response is...
Autores principales: | Jin, Jie, Sunusi, Sadik, Lu, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796086/ https://www.ncbi.nlm.nih.gov/pubmed/35048721 http://dx.doi.org/10.1177/03000605211053156 |
Ejemplares similares
-
Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
por: Herbert, De’Broski R., et al.
Publicado: (2019) -
Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis
por: Kindermann, Markus, et al.
Publicado: (2020) -
Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease
por: Cavagnero, Kellen, et al.
Publicado: (2017) -
Innate lymphoid cells (ILC) in SARS-CoV-2 infection()
por: Kumar, Amrita, et al.
Publicado: (2021) -
Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease
por: Fonseca, Wendy, et al.
Publicado: (2019)